CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🩺

Gastroenterology

55 drugs in pipeline from 10 companies

55

Drugs in Pipeline

10

Companies

9

Upcoming Catalysts

55

Phase 3 Trials

Upcoming Catalysts
Jun '26
RCUSPhase 2

Domvanalimab Phase 2 Est. Readout

Domvanalimab169
Jun 2026~
CT.gov
00%
Jun '26
RCUSPhase 3
Negative

Domvanalimab Phase 3 Results Expected

Domvanalimab1,040
Jun 2026~
CT.gov
Jun '26
GILDPhase 3
Negative

Seladelpar 10 mg Phase 3 Results Expected

Seladelpar 10 mg90
Jun 2026~
CT.gov
Jun '26
SYREPhase 2

SPY001 Phase 2 Est. Readout

SPY001645
Jun 2026~
CT.gov
00%
Jun '26
JNGHFPhase 2

SHR- A1811 Phase 2 Est. Readout

SHR- A1811225
Jun 2026~
CT.gov
00%
Jun '26
MIRMPhase 2
Positive

Volixibat Phase 2 Results Expected

Volixibat182
Jun 2026~
CT.gov
Jun '26
SGIOYPhase 2

Naldemedine Phase 2 Est. Readout

Naldemedine24
Jun 2026~
CT.gov
00%
Jun '26
HRTXPhase 2

B10 L-BPA Injection Phase 2 Est. Readout

B10 L-BPA Injection10
Jun 2026~
CT.gov
00%
2d
days
BNTXPhase 3
Positive

Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose Phase 3 Results Expected

Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose4,292
Jun 16
CT.gov
Pipeline by Phase
Phase 3
55